CO6491043A2 - Proceso para la síntesis de ácido (2s, 3ar, 7as)-octahidro-1h- indol carboxílico como intermediario para trandolapril - Google Patents

Proceso para la síntesis de ácido (2s, 3ar, 7as)-octahidro-1h- indol carboxílico como intermediario para trandolapril

Info

Publication number
CO6491043A2
CO6491043A2 CO12005568A CO12005568A CO6491043A2 CO 6491043 A2 CO6491043 A2 CO 6491043A2 CO 12005568 A CO12005568 A CO 12005568A CO 12005568 A CO12005568 A CO 12005568A CO 6491043 A2 CO6491043 A2 CO 6491043A2
Authority
CO
Colombia
Prior art keywords
trandolapril
compound
octahidro
indol
intermediary
Prior art date
Application number
CO12005568A
Other languages
English (en)
Spanish (es)
Inventor
Sanjay R Chemburkar
Rajarathnam E Reddy
Douglas M Reamer
John T Pavlina
Stephen S Ulrey
Brian Kotecki
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of CO6491043A2 publication Critical patent/CO6491043A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CO12005568A 2009-07-16 2012-01-16 Proceso para la síntesis de ácido (2s, 3ar, 7as)-octahidro-1h- indol carboxílico como intermediario para trandolapril CO6491043A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22603009P 2009-07-16 2009-07-16

Publications (1)

Publication Number Publication Date
CO6491043A2 true CO6491043A2 (es) 2012-07-31

Family

ID=42585097

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12005568A CO6491043A2 (es) 2009-07-16 2012-01-16 Proceso para la síntesis de ácido (2s, 3ar, 7as)-octahidro-1h- indol carboxílico como intermediario para trandolapril

Country Status (10)

Country Link
US (1) US8288565B2 (enExample)
EP (1) EP2454235A1 (enExample)
JP (1) JP2012533563A (enExample)
CN (1) CN102498098A (enExample)
AU (1) AU2010273259B2 (enExample)
CA (1) CA2768239A1 (enExample)
CO (1) CO6491043A2 (enExample)
IN (1) IN2012DN00453A (enExample)
RU (1) RU2012103753A (enExample)
WO (1) WO2011009021A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111620788B (zh) * 2020-04-20 2022-09-30 广东莱佛士制药技术有限公司 一种制备(2s,3s)-3-氨基-二环[2.2.2]辛烷-2-甲酸酯的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487932A (en) 1892-12-13 George b
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
GR78413B (enExample) * 1981-12-29 1984-09-27 Hoechst Ag
US4490386A (en) 1982-09-23 1984-12-25 Warner-Lambert Company Phosphate salts of 1-[2-[(1-alkoxycarbonyl-3-aralkyl)-amino]-1-oxoalkyl]octahydro-1H-indole-2-carboxylic acids, preparation of, and medical compositions thereof
US4556655A (en) 1984-09-24 1985-12-03 Schering Corporation Antihypertensive compounds having both diuretic and angiotensin converting enzyme inhibitory activity
FR2605630B1 (fr) 1986-10-22 1989-06-30 Roussel Uclaf Procede de preparation de derives de l'octahydroindole et intermediaires de preparation
DE19900205A1 (de) 1999-01-07 2000-07-13 Basf Ag Verfahren zur Herstellung von (2S,4R,9S)-Octahydro-1H-indol-2-carbonsäure und Zwischenprodukte dafür
JPWO2004065368A1 (ja) 2003-01-21 2006-05-18 大原薬品工業株式会社 トランドラプリル合成中間体の製造方法
DK1354874T3 (da) * 2003-04-15 2005-03-14 Servier Lab Fremgangsmåde til syntese af (2S,3aS,7aS)-perhydroindol-2-carboxylsyre og estere heraf og anvendelse heraf ved syntese af perindopril
SI21507A (sl) 2003-05-16 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo spojin z ace inhibitornim delovanjem
US20070225505A1 (en) * 2003-11-25 2007-09-27 Pau Cid Method for the Preparation of (2S, 3AR, 7AS)-Octahydro-III-Indole-2-Carboxylic Acid as Key Intermediate in the Preparation of Trandolapril by Reacting a Cyclohexyl Aziridine with a Dialkyl Malonate
WO2005051909A1 (de) 2003-11-28 2005-06-09 Azad Pharmaceuticals Ingredients Ag Verfahren zur herstellung von {n-[1-(s)-carbalkoxy-3-phenylpropyl]-s-alanyl-2s, 3ar, 7as-octahydroindol-2-carbonsäure}verbindungen
WO2006014916A2 (en) 2004-07-26 2006-02-09 Dr. Reddy's Laboratories Ltd. Preparation of trandolapril
US20080171885A1 (en) 2005-02-14 2008-07-17 Lupin Limited Process for Preparation of Highly Pure Trandolapril
DE602005004897D1 (de) 2005-05-06 2008-04-03 Sochinaz Sa Verfahren zur Herstellung von i(2S, 3aR, 7aS)-octahydroindole-2-Carbonsäure und Umwandlung zum Trandolapril
WO2007003947A2 (en) 2005-07-05 2007-01-11 Cipla Limited Process for the synthesis of the ace inhibitor trandolapril
CN101808990B (zh) 2007-07-24 2012-09-05 百时美施贵宝公司 作为趋化因子受体活性调节剂的哌啶衍生物
CN101423490B (zh) * 2008-06-16 2012-07-18 重庆南松医药科技股份有限公司 群多普利关键中间体(2S,3aR,7as)-八氢-1H-吲哚-2-羧酸的合成方法

Also Published As

Publication number Publication date
EP2454235A1 (en) 2012-05-23
RU2012103753A (ru) 2013-08-27
WO2011009021A1 (en) 2011-01-20
US20110065930A1 (en) 2011-03-17
US8288565B2 (en) 2012-10-16
IN2012DN00453A (enExample) 2015-05-15
AU2010273259B2 (en) 2013-03-07
JP2012533563A (ja) 2012-12-27
CA2768239A1 (en) 2011-01-20
AU2010273259A1 (en) 2012-02-09
CN102498098A (zh) 2012-06-13

Similar Documents

Publication Publication Date Title
MX2012003539A (es) Derivados de indol como moduladores de los canales de calcio activados por la liberacion de calcio (crac).
UA106611C2 (uk) Інгібітори зовнішнього медулярного калієвого каналу нирок
UA111933C2 (uk) Піролопіридини як інгібітори кінази
EA201101618A1 (ru) Арилпиридины в качестве ингибиторов альдостеронсинтазы
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
PH12011502619A1 (en) Enantiomers of spiro~oxindole compounds and their uses as therapeutic agents
EA201100161A1 (ru) Производные хинуклидина карбоната и их медицинские композиции
BR112012018386A2 (pt) "inibidores isoindolinona de fosfatidilinositol 3-quinase"
ECSP12011866A (es) Proceso para la preparación de calcobutrol
CY1117261T1 (el) [4-(5-αμινομεθυλο-2-φθορο-φαινυλο)-πιπεριδιν-1-υλο]-[7-φθορο-1-(2-μεθοξυ-αιθυλο)-4τριφθορο μεθοξυ-1η-ινδολ-3-υλο]-μεθανονη ως αναστολεας τρυπτασης maστοκυτταρων
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
MX2011011733A (es) Inhiibidores de dihidroorotato deshidrogenasa como compuestos virostaticos.
IN2012DN01273A (enExample)
EA201000362A1 (ru) Производные 1,3-дигидроизоиндола
EA201101147A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
ATE466854T1 (de) 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren
EA201071183A1 (ru) Безводная кристаллическая форма малеата орвепитанта
EA201071120A1 (ru) Способ получения гетероарилбензопроизводных сульфаматов и кристаллической формы n-((2s)-6-хлор-2,3-дигидро-l,4-бензодиоксин-2-ил)метилсульфамида
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
MX352548B (es) Compuestos disustituidos de tetrahidrofuranilo como antagonistas de receptor de bradiquinina b1.
CO6491043A2 (es) Proceso para la síntesis de ácido (2s, 3ar, 7as)-octahidro-1h- indol carboxílico como intermediario para trandolapril
PH12012501974A1 (en) Novel hypoglycemic compounds
TR201907381T4 (tr) Beta-laktamil fenilalanin, sistein ve serin vazopressin antagonisti.
EA201290534A1 (ru) Бициклические тиазолы в качестве аллостерических модуляторов mglur5 рецепторов
SV2011003923A (es) 3-aminociclopentancarboxamidas

Legal Events

Date Code Title Description
FG Application granted